Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
3.08 USD | 0.00% | -12.99% | +146.40% |
May. 08 | Lexaria Bioscience Corp. Begins Dosing of Its Second Glp-1 Human Pilot Study | CI |
Apr. 16 | Lexaria Obtains Ethics Review Board Approval to Start New GLP-1 Study | MT |